Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Kidney International|June 7, 2013
Subcutaneous interstitial pressure and volume characteristics in renal impairment associated with edemaLeonard M Ebah, Helge Wiig, Idalia Dawidowska, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 2, 2012
Proof-of-principle study to detect metabolic changes in peritoneal dialysis effluent in patients who develop encapsulating peritoneal sclerosisWarwick B Dunn, Angela Summers, Marie Brown, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|January 21, 2014
Towards radiological diagnosis of abdominal adhesions based on motion signatures derived from sequences of cine-MRI imagesJohn Fenner, Benjamin Wright, Jonathan Emberey, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Recessive NPHS2 (Podocin) mutations are rare in adult-onset idiopathic focal segmental glomerulosclerosisNing He, Alireza Zahirieh, Yan Mei, et al.
Journal of the American Society of Nephrology : JASN|July 20, 2007
Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36Andrew D Paterson, Xiao-Qing Liu, Kairong Wang, et al.
Journal of the American Society of Nephrology : JASN|January 30, 2021
Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA NephropathyMark Canney, Sean J Barbour, Yuyan Zheng, et al.
Kidney International Reports|May 15, 2020
Proteomic Analysis of Complement Proteins in Membranous NephropathyAishwarya Ravindran, Benjamin Madden, M Cristine Charlesworth, et al.
Plos One|April 27, 2023
Membranous nephropathy in the UK BiobankPatrick Hamilton, Kieran Blaikie, Stephen A Roberts, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 17, 2008
Phase I trial of rosiglitazone in FSGS: I. Report of the FONT Study GroupMelanie S Joy, Debbie S Gipson, Mary Dike, et al.
Pageof 9